Powerful graft-versus-leukemia effects exerted by HLA-haploidentical grafts engrafted with a reduced-intensity regimen for relapse following myeloablative HLA-matched transplantation.
Ogawa
Hiroyasu
H
Ikegame
Kazuhiro
K
Kawakami
Manabu
M
Tsuboi
Akihiro
A
Kim
Eui Ho
EH
Hosen
Naoki
N
Murakami
Masaki
M
Fujioka
Tatsuya
T
Masuda
Tomoki
T
Taniguchi
Yuki
Y
Yoshihara
Satoshi
S
Tatekawa
Toyoshi
T
Oka
Yoshihiro
Y
Kawase
Ichiro
I
Soma
Toshihiro
T
Oji
Yusuke
Y
D017809:Fatal Outcome; D006086:Graft vs Host Disease / Q000188:drug therapy; D020544:Graft vs Leukemia Effect / Q000502:physiology*; D006680:HLA Antigens / Q000276:immunology*; D006239:Haplotypes; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007938:Leukemia / Q000276:immunology / Q000628:therapy*; D008212:Lymphocyte Depletion; D008297:Male; D033581:Stem Cell Transplantation / Q000009:adverse effects*; D013601:T-Lymphocytes / Q000276:immunology
D006680:HLA Antigens; D007166:Immunosuppressive Agents